NEONC TECHNOLOGIES HOLDINGS
NTHINASDAQTrading Snapshot
- Day Range
- $3.00 – $3.19
- 52-Week Range
- $2.50 – $12.00
- Volume (shares)
- 33,767.115
- Avg Volume (shares)
- —
- Shares Outstanding
- 28.8M
- Next Earnings
- 2026-11-12
Fundamentals Snapshot
- Annual Revenue
- $39,990
- Last Q Revenue
- —
- P/E Ratio
- -1.4
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-1.91
- Dividend Yield
- 0.00%
NEONC TECHNOLOGIES HOLDINGS
NTHIFinancial history unavailable.
StockOtter · stockotter.spaceAbout NEONC TECHNOLOGIES HOLDINGS
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries
DENVER, Oct. 26, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) — NeOnc Technologies Holdings (NASDAQ: NTHI) is setting its sights on a substantially larger international clinical effort, outlining plans for a trial targ
NeOnc Breaks Through Key Levels, as Brain-Cancer Stock's Catalysts Continue
DENVER, Oct. 23, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — NeOnc Technologies Holdings (NASDAQ:NTHI) cleared several key resistance levels, on strong trading volume, delivering a potentially important technical sign
NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight
NeOnc (NASDAQ: NTHI) is taking its brain cancer story to Fox Business Network when several developments put the clinical-stage biotech in the spotlight
NeOnc Technologies to Be Featured on Health Uncensored with Dr. Drew to Discuss Reaching Brain Tumors Without Surgery or Systemic Chemotherapy
CALABASAS, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing therapies for central nervous system
NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches
Compassionate care for children in Abu Dhabi, a new research MoU and a senior banking appointment add momentum to NeOnc's development story Houston, Texas--(Newsfile Corp. - October 21, 2026) - As NeOnc Technologies Hold
NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward
DENVER, Oct. 21, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) — “I wish someone had told me about that company.” That is a familiar reaction when a stock attracts attention after investors have spent months overlooking